Nestlé S.A. (SWX:NESN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
80.48
-0.69 (-0.85%)
Apr 27, 2026, 5:30 PM CET

Nestlé Earnings Call Transcripts

Fiscal Year 2026

  • Q1 2026 saw 3.5% organic sales growth, led by Coffee and emerging markets, despite headwinds from an infant formula recall and currency impacts. Guidance for 2026 is unchanged, with a focus on RIG-led growth, portfolio optimization, and resilience amid geopolitical uncertainties.

  • AGM 2026

    A new independent Chair and CEO outlined a renewed strategic focus on core businesses, efficiency, and innovation, with a proposed dividend increase and strengthened governance. The board is being refreshed, and cost savings of CHF 3 billion are targeted by 2027.

Fiscal Year 2025

  • Nespresso remains globally managed, while the company sharpens focus on four strategic pillars and divests its remaining ice cream businesses to Froneri. The infant formula recall's direct impact is contained, with enhanced quality controls in place and organic growth guidance set at 3–4%.

  • Growth accelerated in 2025 with 3.5% organic growth and strong free cash flow, despite margin pressure from input costs and a significant infant formula recall. 2026 guidance targets 3–4% organic growth, margin improvement, and over CHF 9 billion free cash flow, with continued portfolio focus and efficiency gains.

  • Year-to-date organic growth accelerated to 3.3% with strong Q3 momentum, driven by investments in priority areas and improved performance in underperforming segments. Major restructuring and efficiency initiatives are underway, with a focus on RIG-led growth and a medium-term margin target above 17%.

  • A new CEO with a strong track record has been appointed following a conduct investigation, with succession planning enabling a swift transition. Operational focus is on standardized KPIs, targeted innovation, and addressing underperformers. Pet food and coffee remain growth drivers, while pricing actions and cost efficiencies support margin guidance despite external pressures.

  • Organic sales grew 2.9% in H1 2025, with U-top margin at 16.5% despite FX and input cost headwinds. Full-year guidance is maintained, but H2 margins will be lower due to rising costs and tariffs. Strategic focus includes efficiency gains, premiumization, and a shift in China to consumer demand.

  • Leadership is driving alignment and transformation by focusing on core brands, innovation, and operational efficiency. Strategic investments target high-potential categories, while productivity gains and technology adoption support sustainable growth. Consumer trends in health, wellness, and pet care remain strong.

  • Organic sales grew 2.8% in Q1 2025, driven by pricing actions in coffee and cocoa amid cost inflation. Guidance for 2025 remains unchanged, with improved organic growth and a UTOP margin at or above 16% as cost savings and investments in brands continue.

  • AGM 2025

    2024 was marked by global instability and inflation, impacting growth and trust. Leadership changes, a robust cost savings program, and strategic focus on core brands and innovation aim to accelerate performance. Dividend increases and board strengthening reflect confidence in future growth.

  • 2024 results met or exceeded guidance, with a focus on efficiency and reinvestment to drive medium-term growth above 4%. Key strategies include expanding core brands, prioritizing innovation, and addressing underperformance, especially in the Americas, while leveraging digitalization and sustainability.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018

Fiscal Year 2017

Fiscal Year 2016

Fiscal Year 2015

Fiscal Year 2014

Fiscal Year 2013

Fiscal Year 2012

Fiscal Year 2011

Fiscal Year 2010

Powered by